A broad portfolio for monitoring molecular and serology testing
Bio-Rad offers a wide range of infectious disease quality controls for both serology (antibody) and molecular (nucleic acid) testing. Our controls include tests for hepatitis and retrovirus as well as for sexually-transmitted, congenital, and respiratory diseases. They are compatible across platforms, meet international standards, and are manufactured according to the ISO 17511 standard. Long shelf lives help ensure performance of your assay and provide greater confidence in patient test results.
With quality controls covering a wide range of infectious diseases, Bio-Rad’s portfolio substantially helps meet your QC testing needs. Our controls are derived from human plasma and are compatible with major infectious disease platforms.
Our independent, high-quality controls meet strict quality metrics and are manufactured according to the ISO 17511 requirement. This helps to ensure reliable patient test results.
Our molecular controls offer verification panels, which help labs establish or verify performance characteristics, and daily run controls, which allow labs to monitor performance over time—providing added confidence in your test results.
Use our standard as a reference material against five gene targets for research testing of the novel coronavirus.
Detect testing deficiencies for total IgG/IgM and IgG antibodies to SARS-CoV-2 using our human plasma–formulated VIROTROL and VIROCLEAR SARS-CoV-2 controls.
Use our multi-analyte control, which contains 22 common respiratory analytes, to validate the testing of the entire process of your molecular assay.
We offer molecular standards and quality control products for the testing of
pathogens in the areas of transplant, respiratory, virology, microbiology, hospital-acquired
infections, sexually-transmitted infections, and vector-borne diseases. Our molecular controls deliver
traceability, commutability, and absolute quantification to high-impact molecular testing.
We have a broad range of serology quality controls in the areas of hepatitis,
retrovirus, as well as congenital/pediatric, sexually-transmitted, and respiratory infectious
diseases. Our serology controls are formulated to challenge the cutoff of your serology assay to help ensure
confidence in laboratory test results.
Broad portfolio increases range of molecular and serology testing
Less crossover studies improves efficiency
Performance characteristics can be established and verified
Cross-platform compatibility streamlines workflow
Human plasma–based matrix similar to patient samples
Molecular controls are calibrated to meet international standards
Learn more about how advanced quality controls can improve patient outcomes. Discussion points include the connection between quality standards and patient outcomes, why traditional quality control techniques need to be adapted, and more.
This informative article highlights relevant QC considerations for molecular diagnostics and presents effective QC solutions to support a dynamic and evolving molecular laboratory.
This article presents the essentials of setting up a system for verifying and maintaining a desired level of quality in an existing product or service through careful planning, use of proper equipment, continued inspection, and corrective action as required.
Some benefits for registering